News

Current Events

European Cancer Moonshot Lund Center team member Jonatan Eriksson giving a half-time research presentation on his study focused on drug imaging.

The European Cancer Moonshot is proud to be partners with the Spartacus Cancer Foundation, and their ongoing development of their state of the art Bio-Bank. Members of the Cancer Moonshot Lund team were on hand when the new compressors were being delivered to our partners in Szeged, Hungary.

This image has an empty alt attribute; its file name is sz.jpg

This image has an empty alt attribute; its file name is sz1.jpg

This image has an empty alt attribute; its file name is sz2.jpg

In September, 2020, the European Cancer Moonshot Lund Center expanded our lab with a new tumor tissue preparation section. With this, we can more efficiently process our samples.

Patients being air lifted from Lund University Hospital.

Dr. Gyorgy Marko-Varga and Dr. Johan Malm visiting research partners Inova Cancer Center in Virginia, USA.

In late 2019, European Cancer Moonshot Lund Center team members were on hand for the founding of the Spartacus Cancer Foundation in Szeged, Hungary.

Featured Videos

Prof. Mark Baker discussing Proteomics at the HUPO conference in Orlando, Florida in 2018.

Publicity in newspapers/magazines/web pages during 2017/2018

https://www.hupo.org/HUPOST/6272223

http://www.lth.se/labib/aktuellt/show-news/article/european-cancer-moonshot-lund-symposium/

http://www.euni.de/tools/jobpopup.php?lang=en&jobid=3119&jobtyp=9&university=Lund+University

http://www.lakemedelsvarlden.se/lund-blir-del-i-cancer-moonshot/

http://news.cision.com/se/bewi-group/r/symposium-i-lund-23-maj-2018-inom-ramen-for-cancer-moonshot—storsta-globala-satsningen-nagonsin-fo,c2516663

https://www.sydsvenskan.se/2017-09-13/lundaprofessor-ska-leda-nytt-cancercenter

https://www.dn.se/nyheter/vetenskap/svenska-forskare-i-jattesatsning-mot-cancer/

https://www.metro.se/artikel/lundaprofessor-ska-leda-nytt-cancercenter-xt

http://www.lth.se/nyheter-och-press/fler-nyheter/article/prof-marko-varga-part-of-cancer-moonshot-initiati/

https://www.dagensmedicin.se/artiklar/2017/09/13/lundaprofessor-ska-leda-nytt-cancercenter/

https://www.hd.se/2017-09-13/lundaprofessor-ska-leda-nytt-cancercenter

www.regeringen.se/debattartiklar/2016/10/nytt-avtal-sverige-och-usa-ska-samarbeta-om-cancerforskning/

Featured Publications 

Toshihide Nishimura, Haruhiko Nakamura, Akos Vegvari, Gyorgy Marko-Varga, Naoli   

   Furuya, and Hisashi Saji. “Current status of clinical proteogenomics in lung cancer”, Expert

   Review of Proteomics, V-1 I-9, 2019.

https://www.tandfonline.com/doi/full/10.1080/14789450.2019.1654861

Szasz M., Malm J., Rezeli M., Betancourt L. H., Rivas D., Gyorffy B., and Marko-

          Varga G., “Challenging the Heterogeneity of Disease Presentation of Melanoma Cancer –

          Impact on Patient Treatment” Cell Biol. Tox., 35. 1, 1-14, 2019  

 https://doi.org/10.1007/s10565-018-9446-9

Rodriguez Murillo J., Kuras M., Rezeli M. Milliotis T., Betancourt L. and

Marko-    Varga G., “Automated Phosphopeptide Enrichment from Minute  

        Quantitation of Frozen alignant Melanoma Tissue”, PLoSOne 2018, Dec 10; 

    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0208562

 Kuras M., Betancourt, L., Rezeli M.,  Rodriguez J., Zhou Q., Miliotis T.,

          Andersson R., Marko-Varga G ., Accessing Automatic Sample Preparation Technologies  

          for High-throughput Proteomics of Frozen Sectioned Tissues from Swedish Biobanks”,  J.   

         Proteome Res., 201918 (1), pp 548–556

.   Sugihara Y.,Rivas D. B., Malm, Szasz M., Kwon H-J., Baldetorp B., Olsson H., Ingvar

          C., Rezeli M. Fehniger T. E.., and Marko-Varga G., Endogenous Expression Mapping

          of Malignant Melanoma Tumours by Mass Spectrometry Imaging, 2018, Clin Transl.

          Med., 7:22, https://doi.org/10. /s40169-018-0201-x

Betancourt L., Kuras M., Rezeli M., Marko-Varga G ”Quantitative assessment of urea

         in-solution protein digestion reveals superior performance at room temperature over   

          traditional hydrolysis at 37°C” 2018 J. Proteome Res. Jul 6;17(7):2556-2561

         https://pubs.acs.org/doi/pdf/10.1021/acs.jproteome.8b00228

Malm J., Szasz M., Sugihara Y, Kwon H-J, Appelqvist R., andMarko-Varga G,

          Biobank Integration of Large-scale Clinical and Histopathology Studies within the European

          Cancer Moonshot Lund Center, Clin Transl. Med. 2018, Aug 20;7(1):28

         doi: 10.1186/s40169-018-0203-8  

WelinderC., Pawłowski K., Szasz M., Sugihara Y., Jönsson G., Ingvar C., Lundgren

          L., Baldetorp B., Olsson H., Malm J., Rezeli M., Laurell T., Wieslander E., and

          Marko-VargaG “Correlation Pathology Characteristics to Protein Expression and

          Protein Function in MalignantMelanoma”, PLoS One. 2017 Apr 26;12(4):e0176167,

           doi: 10.1371/journal.pone.0176167.

Török S., Rezeli M., VegvariA., Watanabe K., Sugihara Y, Tisza A., Marton T.,

          KelemenO., Hegedus B., Tovari J., Helbich T, Laszlo V., Paku S., Marko-VargaG.,         

          Döme B., “Limited tumor tissue dug penetration contributes to primary resistance       

          against angiogenesis inhibitors”,  Theranostics., 2017, 7, 400-412

Marko-VargaG., J., “In Memoriam Thomas Fehniger” J. Proteome Res., 2017,

         16(1)

Szasz M., Györffy B., and Marko-Varga G., “Cancer Heterogeneity Determined by

Functional Proteomics” Sem Cell & Dev. Biol., 2016, S1084-9521, 16)30270-1. doi: 10.1016/j.semcdb.2016.08.026.

          http://www.sciencedirect.com/science/article/pii/S1084952116302701

          DOI:10.1016/j.semcdb.2016.08.026